Bright Minds Biosciences (DRUG) stays a Strong Buy after Phase 2 BMB-101 seizure-reduction data; see 2026 catalysts, ...
A preclinical study uncovered a new gene therapy that targets pain centers in the brain while eliminating the risk of ...
U.S. Food and Drug Administration (FDA) allows advancement of RAP-219 into registrational trials for focal onset seizures (FOS); accelerated initiation of Phase 3 program expected in the second ...
Doncaster Free Press on MSN
Doncaster man, 31, almost dies after 'running injury' turns out to be a sign of deadly brain cancer
A man's 'running injury' turned out to be a sign of deadly cancer. Sean Ryan Sweeney, aged 31, began experiencing frequent ...
Sean Ryan Sweeney, 31, was diagnosed with a grade 3 astrocytoma after suffering from frequent headaches, neck pain and a ...
He thought he'd torn a ligament in his neck while running or weight training and went to a physiotherapist, but had no relief ...
He recalled: "Then, everything escalated suddenly. I was woken in the early hours by my partner, Lucy (now my wife), after I ...
Migraines affect millions in the UK, yet are often misunderstood and underestimated. From throbbing pain and nausea to ...
A federal judge declined last month to dismiss the claims against numerous prison employees for a man's in-custody death ...
Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) ('Tonix” or the 'Company”), a fully-integrated commercial stage biotechnology company, today announced it has entered into a securities purchase ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback